Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Hold
211
﹤0.01% 800
2026
Q1
$11.6K Buy
211
+22
+12% +$1.19K ﹤0.01% 783
2025
Q4
$9.27K Hold
189
﹤0.01% 757
2025
Q3
$8.16K Hold
189
﹤0.01% 730
2025
Q2
$7.26K Buy
+189
New +$7.22K ﹤0.01% 747

Other funds holding GSK

GHP Investment Advisors's GSK Position: Q2 2026 in Review

GHP Investment Advisors held its GSK (GSK) position steady in Q2 2026 at 211 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #800.

GHP Investment Advisors first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. The position peaked at $11.6K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • GHP Investment Advisors held 211 shares of GSK worth $11.1K as of Q2 2026.
  • GHP Investment Advisors left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #800 holding.
  • GHP Investment Advisors first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • GHP Investment Advisors's GSK position peaked at $11.6K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.